Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy
NCT ID: NCT01938313
Last Updated: 2017-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
100 participants
INTERVENTIONAL
2012-08-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal Gastrectomy
NCT03079596
Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy
NCT06984952
The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy
NCT03160924
Compliance to ERAS After Gastric Surgery
NCT01653496
Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Gastrectomy
NCT03016026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, few studies exist about the implication of ERAS programs in the laparoscopic gastrectomy.
The aim of this study was to compare the recovery rate, morbidity, and quality of life in the patients undergoing laparoscopic gastrectomy for gastric cancer, receiving either ERAS protocol or conventional postoperative cares.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ERAS perioperative cares
Patients planned to undergoing laparoscopic gastrectomy, following the ERAS protocols.
ERAS perioperative cares
1. Patient's preoperative counseling \& education before surgery
2. No Bowel preparation
3. Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Fluid restriction \& Management by pulse contour analysis or transesophageal doppler
5. Early mobilization
6. Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD))
7. Epidural patient controlled analgesics (no opioids analgesics)
8. Postoperative Nausea Active Control
9. Thromboembolism prophylaxis by low molecular weighted heparin (LMWH)
10. Perioperative High content Oxygen therapy
11. No drain insertion
12. No Levin tube
13. Patients will be discharged at POD#4 if there's no problem.
Conventional perioperative cares
Patents will be managed by our hospital's critical pathways.
Conventional perioperative cares
1. No Patient's preoperative counseling \& education before surgery
2. Bowel preparation
3. No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Conventional Fluid Management by clinical signs (Urine output, heart rate etc.)
5. Conventional Mobilization
6. Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD)
7. IV PCA
8. Postoperative Nausea Control if needed
9. No Thromboembolism prophylaxis
10. No or Low Content Oxygen therapy
11. Routine drain insertion
12. Levin tube insertion if needed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERAS perioperative cares
1. Patient's preoperative counseling \& education before surgery
2. No Bowel preparation
3. Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Fluid restriction \& Management by pulse contour analysis or transesophageal doppler
5. Early mobilization
6. Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD))
7. Epidural patient controlled analgesics (no opioids analgesics)
8. Postoperative Nausea Active Control
9. Thromboembolism prophylaxis by low molecular weighted heparin (LMWH)
10. Perioperative High content Oxygen therapy
11. No drain insertion
12. No Levin tube
13. Patients will be discharged at POD#4 if there's no problem.
Conventional perioperative cares
1. No Patient's preoperative counseling \& education before surgery
2. Bowel preparation
3. No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery
4. Conventional Fluid Management by clinical signs (Urine output, heart rate etc.)
5. Conventional Mobilization
6. Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD)
7. IV PCA
8. Postoperative Nausea Control if needed
9. No Thromboembolism prophylaxis
10. No or Low Content Oxygen therapy
11. Routine drain insertion
12. Levin tube insertion if needed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) scores \< 3
* 20 \< Age \< 80
* Gastric cancer, adenocarcinoma, possible to perform laparoscopic distal gastrectomy
* Informed consent
* No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer or other type of cancer.
* No systemic inflammatory disease
Exclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyung-Ho Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyung-Ho Kim, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Surgery, SNUBH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam, Geynggi, South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kang SH, Lee Y, Min SH, Park YS, Ahn SH, Park DJ, Kim HH. Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Prospective, Randomized, Clinical Trial. Ann Surg Oncol. 2018 Oct;25(11):3231-3238. doi: 10.1245/s10434-018-6625-0. Epub 2018 Jul 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUBH-ERAS-GC-PII
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.